checkAd
    Startseite > Aktien > AXIM Biotechnologies > Nachrichten
    AXIM Biotechnologies Aktie
    0,0148
     
    USD
    +7,25 %
    +0,0010 USD
    Letzter Kurs 30.04.24 Nasdaq OTC
    ISIN: US05463V1008 · WKN: A2DF26 · SYM: AXIM · USA

    Neueste Nachrichten

    VIDEO: AXIM Biotechnologies CEO Presents at Benzinga Virtual Healthcare Summit 2024
    27.03.24 · globenewswire · AXIM Biotechnologies
    AXIM Biotechnologies’ Tear Based Testing Platform Continues to Gain Traction After Successful Clinical Validation
    20.02.24 · globenewswire · AXIM Biotechnologies
    AXIM Biotechnologies Partners With Leading Diagnostic Manufacturer Auer Precision to Scale Assay Production
    20.12.23 · globenewswire · AXIM Biotechnologies
    AXIM Biotechnologies Develops First Non-Invasive, Rapid, Point-of-Care, Diagnostic Test for Parkinson’s Disease
    12.09.23 · Business Wire (engl.) · AXIM Biotechnologies
    AXIM Biotechnologies Receives Notice of U.S. Patent Allowance for Three Separate Patents Including Its Rapid Point of Care Neutralizing Antibody Test
    01.08.23 · Business Wire (engl.) · AXIM Biotechnologies
    Update: AXIM Biotechnologies Starts Shipping Revenue Generating IgE Diagnostic Validation Assays to Customers Nationwide
    12.07.23 · globenewswire · AXIM Biotechnologies
    AXIM Biotechnologies Starts Shipping Revenue Generating IgE Diagnostic Validation Assays to Customers Nationwide
    12.07.23 · globenewswire · AXIM Biotechnologies
    AXIM Biotechnologies Announces Over 40 Initial Clinic Commitments for Its Full Diagnostic Assay Platform Launch
    24.05.23 · globenewswire · AXIM Biotechnologies
    AXIM Biotechnologies Appoints Kurt Phinney as Chief Operating Officer to Drive Scaling and Optimization of Manufacturing Unit
    23.05.23 · globenewswire · AXIM Biotechnologies